Primary Image

Transfemoral Osseointegration

Clinical Trial

Evaluation of Powered Prosthesis for use with Transfemoral Osseointegration Recipients

IRB Protocol Number STU00215805

Contact

cbm@sralab.org

Objective

To evaluate the benefits of osseointegration (OI) on functional, biomechanical, and metabolic outcomes as well as user satisfaction and powered prosthesis control for individuals with a transfemoral amputation who have received target muscle reinnervation (TMR) and OI surgery.

Who Can Participate

Participants must:

  • Have an amputation at the transfemoral level
  • Be able to ambulate with their current prosthesis
  • Be a candidate for OI surgery, as verified by a surgical team (or has previously received OI)
  • Be a candidate for TMR surgery, as verified by a surgical team (or has previously received TMR)

For additional information, please contact:

cbm@sralab.org

Compensation

Compensation will be provided.

Age Range

18-70

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan AbilityLab. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all